2005 Leads Networking 
European Pharmaceutical Review
MARCH 15, 2023
This creates a need for flexible and scalable software tools for data processing, according to Robin Schmid from Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) and UC San Diego (CA, USA), project lead architect and one of the first authors of the paper.
PM360
MARCH 24, 2023
Within the past 40 years, 202 new awareness days were introduced to Congress—71% of these were introduced after 2005. It’s because social media networks proved to have tremendous power in fostering communities. It’s because social media networks proved to have tremendous power in fostering communities.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 6, 2022
Not only does the appearance of a common symptom – such as a fever, for example – lead to potential misdiagnoses, but it can also lead to clinicians choosing ineffective therapies that treat symptoms, rather than the true cause of a disease.
Pharma Marketing Network
MAY 3, 2023
However, the effects of these advertisements are not always positive, as they can also lead to overdiagnosis, overtreatment, and higher healthcare costs. Healthcare providers may be influenced by the advertisements they see, leading them to prescribe specific medications more frequently than others. References: 1. Goozner, M.
Clarivate
MAY 8, 2023
The ‘If I Knew Then What I Know Now’ panel has for 15 years been a staple of the annual conference , which brings together biotech companies and investors in London for networking, company presentations and plenary discussions. KuDOS’ lead asset, cancer drug olaparib (AKA LYNPARZA®), went on to generate sales of $2.9
European Pharmaceutical Review
MARCH 1, 2023
The honeycomb-like pore structure, which can be seen in elegant cakes, fades into an irregular network with rod-like structures, which are partially collapsed and have drop-shaped ends. PharmTech 2005 Apr 1. J Food Science 2005; 70(7): e437-e442 [[link] 5. Int J Pharm 2004; 271(1-2): 215–24 [[link] 15129988] 2. X-Ray Spectrom.
European Pharmaceutical Review
APRIL 21, 2023
Giving environmental risk assessments teeth Since 2005, the authorisation of a human pharmaceutical product requires an environmental risk assessment (ERA). In addition, the number of active substances detected in the environment has been increasing with unknown consequences for ecosystems and the accumulation of substances in food chains.
Expert insights. Personalized for you.
139 
Let's personalize your content